Publicaciones
-
Acosta S, Mayol G, Rodriguez E, Lavarino C, de Preter K, Kumps C, Garcia I, de Torres C and Mora J.
Identification of tumoral glial precursor cells in neuroblastoma
CANCER LETTERS . 312(1): 73-81. Nº de citas: 12
-
Garcia I, Mayol G, Rodriguez E, Suñol M, Gershon TR, Ríos J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casalà C, Galván P, de Torres C, Mora J and Lavarino C.
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
MOLECULAR CANCER . 9: 277-277. Nº de citas: 58
-
De Preter K, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, Janoueix-Lerosey I, Lavarino C, Maris JM, Mora J, Nakagawara A, Oberthuer A, Ohira M, Schleiermacher G, Schramm A, Schulte JH, Wang Q, Westermann F, Speleman F and Vandesompele J.
Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
CLINICAL CANCER RESEARCH . 16(5): 1532-1541. Nº de citas: 76
-
de Torres C, Beleta H, Díaz-Naderi R, Toran N, Rodríguez E, Lavarino C, García I, Acosta S, Suñol M and Mora J.
The Calcium-Sensing Receptor and Parathyroid Hormone-related Protein Are Expressed in Differentiated, Favorable Neuroblastic Tumors
CANCER . 115(12): 2792-2803. Nº de citas: 24
-
Acosta S, Lavarino C, Paris R, Garcia I, de Torres C, Rodríguez E, Beleta H and Mora J.
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
BMC DEVELOPMENTAL BIOLOGY . 9: 12-12. Nº de citas: 50
-
Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M and Mora J.
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
BMC Cancer . 9: 44-44. Nº de citas: 27
-
Lavarino C, Garcia I, Mackintosh C, Cheung NK, Domenech G, Ríos J, Perez N, Rodríguez E, de Torres C, Gerald WL, Tuset E, Acosta S, Beleta H, de Alava E and Mora J.
Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status
BMC MEDICAL GENOMICS . 1: 36-36. Nº de citas: 11
-
Mora J, Lavarino C, Alaminos M, Cheung NK, Ríos J, de Torres C, Illei P, Juan G and Gerald WL.
Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma
GENES CHROMOSOMES & CANCER . 46(4): 385-396. Nº de citas: 7
-
Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J and Ciudad CJ.
Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.
Oligonucleotides . 14(2): 100-113. Nº de citas: 58
-
Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti MA and Pilotti S.
Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.
INTERNATIONAL JOURNAL OF CANCER . 92(6): 790-796. Nº de citas: 43